ArticleFrontiers in oncology2022

Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer.

Feifei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.